The Global Handheld Ultrasound Devices Market was valued at USD 316.9 million in 2024 and is anticipated to reach USD 589.20 million by 2035, expanding at a CAGR of 5.80% during the forecast period 2025-2035. Portable ultrasound units are seen to have practically redefined medical imaging from bulky machinery to portable point-of-care devices, thus facilitating clinicians in numerous clinical settings. Initially confined to high-cost imaging centres, ultrasound technology has now instilled itself firmly in frontline healthcare: emergency rooms, ambulances, and even primary clinics. This transformation has been spurred by a magnified movement towards mobility, decentralised diagnostics, and precision-driven treatment pathways, thus allowing caregivers to make quick decisions at the bedside.
As trauma care, emergency medicine, and critical interventions are increasingly in demand for rapid diagnostic clarity, handheld ultrasound is becoming more and more infused in care protocols. Hospitals have started using ultrasound to fasten triage, detect internal injuries, and guide interventional procedures, while primary clinics use them to open access for patients in under-resourced areas where advanced imaging is limited. This adoption fits broadly within global health initiatives that push for early diagnoses, resource optimisation, and patient-
centric care delivery.
Manufacturers are aligning investments in AI-based imaging enhancement, ergonomics, and wireless compatibility on the supply side to augment the usability of these devices. Increased penetration of handheld ultrasound within urology, obstetrics, cardiology, and trauma care reinforces the disruptive nature of portable imaging. Value-based care and remote monitoring in healthcare ensure that handheld ultrasound devices fulfil their journey from being an adjunctive tool to a front-line diagnostic instrument, disentangling workflows, and widening the reach for clinical expertise through decentralised spaces.
Point-of-care ultrasound speeds up diagnosis in trauma and emergency medicine.
Surgeons manage the rising burden of road accidents, sports injuries, and emergency surgical cases, notwithstanding the imposition of rapid bedside imaging. Ultrasound systems weighing a few kilograms can detect internal bleeding, fractures, or organ damage in minutes, while drastically reducing the time to make a diagnosis and improve patient outcomes in a busy trauma-care unit.
Increasing usage in urology vastly enlarges applications for the handheld ultrasound device.
Urologists have turned to portable ultrasound devices for fast, convenient, and safe imaging as the prevalence of urinary tract problems,
calculus disorders in the kidney, and prostate problems increases. The versatility of handheld probes in bladder scanning and guided catheterisation procedures has made them indispensable in both outpatient and hospital settings, thereby strengthening their long-term adoption.
Technological innovations sustain demand amid reimbursement challenges.
Integrating AI for automated interpretation, machine learning for anomaly detection, and cloud-based data sharing has widely enhanced the devices' applications. Much lower adoption in developing economies, through reimbursement gaps, lack of trained personnel, and questions about image resolution as compared to high-end cart-based systems, are some barriers against these advancements.
With increased rural healthcare access comes an enormous opportunity for growth.
Governments and NGOs are funding mobile diagnostic devices to tackle inequality in the healthcare sector. Handheld ultrasound devices are being employed through rural clinics and mobile healthcare units. Its affordability, ease of use, and portability allow it to become a handy diagnostic tool in areas with a lack of frameworks works creating bright chances for manufacturers eyeing emerging markets.
Growth hampered by supply chain disruptions and regulatory compliance hurdles.
The shortages of semiconductors globally, interruptions in logistics incurred during the pandemic, and strict regulatory approvals for devices have sporadically delayed production and commercialisation. Consequently, players are forced to diversify their manufacturing bases, speed up regulatory clearances and build supply networks at the same time to sustain market momentum.
By End Use: Hospitals, Primary Clinics
By Application: Trauma, Urology
By Region: North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific), LAMEA (Brazil, Argentina, UAE, Saudi Arabia (KSA), Africa Rest of Latin America)
Key Market Players: GE HealthCare, Butterfly Network Inc., Philips, Clarius Mobile Health, Fujifilm Holdings, Samsung Medison, Canon Medical Systems, Mindray, Siemens Healthineers, and Healcerion.
Report Aspects
Base Year: 2024
Historic Years: 2022, 2023, 2024
Forecast Period: 2024-2035
Report Pages: 292
Between all the areas of diagnosis within their four walls, hospitals will be the primary place in which handheld ultrasound devices will be used during the next half-decade.
Emergency departments apply the point of care for trauma diagnostics, and surgery units use them for guided interventions. That versatility allows hospitals to maximise workflow and avoid being attached permanently to a cart, a high-end "conventional" ultrasound. All these factors make hospitals the most lucrative segment of such resource investments on account of the purchasing power.
Primary clinics rise as decentralised diagnostic access expands globally.
With the lowering of expenses and the availability of cheap handheld ultrasound devices, rural and semi-urban primary clinics are turning to investing in these to cover diagnostic gaps. Their affordability, portability, and ease of use in a non-specialist environment make them attractive to these physicians. The primary clinics have been acquiring them for initial assessments of trauma, bladder scans, and pregnancies, emphasising their contribution toward more affordable access to imaging. With these policies insisting on prevention and early diagnosis, this segment is going to develop rapidly.
Trauma applications spearhead handheld ultrasound utility in critical care.
Among the most significant areas of application for handheld ultrasound is trauma care. Portable devices have been crucial in performing FAST tests that guide emergency decisions concerning internal bleeding, fractures, or surgical interventions. With increased worldwide road traffic accidents and emergency cases, the focus of handheld ultrasound is expected to expand into trauma.
The urology segment shows steady growth with non-invasive diagnostic applications.
Handheld ultrasound devices are now indispensable in urology for bladder volume assessment, kidney imaging, and prostate monitoring. The preference for these devices has been owing to their noninvasiveness and the immediate provision of diagnostic insight. As more and more urological disorders develop, especially among the older population, this segment is expected to experience continuous growth as innovations in device development continue.
North America has a strong hospital infrastructure supportive of new technologies and innovations, making it the leader in the handheld ultrasound pack.
Because of the well-established hospital networks, high penetration of advanced diagnostic equipment, and aggressive integration of AI technologies, North America, spearheaded by the United States, is a really strong region for handheld ultrasound adoption. Continuous innovation is enforced by the presence of the dominant players in the region: GE HealthCare, Philips, and Butterfly Network. The region is further strengthened through regulatory incentives favouring point-of-care technologies.
Europe leads the handheld ultrasound adoption, mainly through eco-innovation and clinical integration.
In Europe, a strong emphasis on reducing the environmental impact of technologies and on modernising the health sector is consolidating the handheld ultrasound position. Germany, France, and the UK take precedence in promoting portable ultrasound installations in hospitals and primary care clinics, having secured government backing through funding proposals.
Asia-Pacific is set as the fastest-growing market for handheld ultrasound devices.
The uninterrupted growth of handheld ultrasound in this region is due to rapid expansions in health care facilities in China, India, and Southeast Asia. An abundance of opportunities arises with local governments' initiatives directing attention toward rural healthcare and the expansion of mobile medical services. Furthermore, cost-effective portable diagnostics are set on the path of sustained growth as the pharmaceutical and medical device industries in Asia invest in advancing them.
LAMEA reactivates handheld ultrasound adoption through general healthcare improvement.
There is moderate growth in handheld ultrasound adoption in Latin America, the Middle East, and Africa, with investment in government interest toward healthcare improvement. Imaging services in hospitals are being increased in Brazil and the UAE, while handheld ultrasound devices by NGOs and other aid programs are operational in rural clinics in Africa. Infrastructure gaps do restrain this growth, but increasing partnerships with global players is making it more accessible.
Q. What is the expected growth trajectory of the handheld ultrasound devices market from 2024 to 2035?
The global handheld ultrasound devices market is projected to grow from USD 316.9 million in 2024 to USD 589.20 million by 2035, registering a CAGR of 5.80%. Growth is driven by expanding adoption in hospitals and clinics, rapid trauma and urology applications, and innovations in AI and cloud integration.
Q. Which key factors are fuelling the growth of the handheld ultrasound devices market?
Several key factors are propelling market growth:
Q. What are the primary challenges hindering the growth of the handheld ultrasound devices market?
Major challenges include:
Q. Which regions currently lead the handheld ultrasound devices market in terms of market share?
North America currently leads the handheld ultrasound devices market due to advanced hospital infrastructure, regulatory incentives, and the presence of major global players. Europe follows closely with significant adoption in hospitals and clinics supported by national healthcare programmes.
Q. What emerging opportunities are anticipated in the handheld ultrasound devices market?
The market is ripe with new opportunities, including: